期刊文献+

氨氯地平在健康人体内的药动学和药效学 被引量:4

Study on the pharmacokinetics and pharmacodynamics of amlodipine in healthy chinese subjects
原文传递
导出
摘要 目的:研究苯磺酸氨氯地平片在健康人体的药动学,及血药浓度与降血压效应的关系。方法:24名健康受试者单次口服10 mg苯磺酸氨氯地平片,服药后不同时间采集血样,采用LC-MS-MS法测定血浆中氨氯地平浓度,采用坐位动脉收缩压(SBP)和舒张压(DBP)的变化值为降压药效指标。结果:氨氯地平体内代谢呈二室模型,消除半衰期约36 h,表观分布容积较大,提示为全身分布,峰浓度约为(6.1±1.5)ng.mL-1。动脉收缩压和舒张压在用药后呈波动性下降,用药10 h后药效逐渐消失,可见一个药效滞后环。AUC0-120 h(ng.h.mL-1)和AUEC0-48(mmHg.h-1)分别为(237.1±77.2)和(126.1±49.8)(SBP)、(192.6±47.7)(DBP);Cmax(ng.mL-1)和Emax(mmHg)分别为(6.1±1.5)和(6.3±3.2)(SBP)、(10.1±2.9)(DBP);tmax(h)和TEmax(h)分别为(3.9±0.7)和(8.1±2.3)(SBP)、(9.2±1.2)(DBP)。结论:苯磺酸氨氯地平对动脉收缩压和舒张压均有降低作用,药效达峰时间在给药后6~10 h,均呈现较好的滞后效应。 OBJECTIVE To study the pharmacokinetics and pharmacodynamics of amlodipine in healthy subjects and explore the relationship between the blood concentration of amlodipine and the antihypertensive effect. METHODS 24 male volunteers were administered 10 mg amlodipine by single dose.The blood samples of different time points in these subjects were sampled and the drug concentrations of amlodipine were analyzed by LC-MS-MS,and the primary variables measured in this study were systolic and diastolic blood pressure(SBP and SDP) and pulse rate in a sitting position. RESULTS Amlodipine was a two-compartment model with slow elimination(t1/2,36 h) and a large apparent volume of distribution.The Cmax was(6.1±1.5)ng·mL-1.SBP and SDP were depressed after administration,and it was related to the change of drug concentration.The efficacy hysteresis rings were found from the curves of efficacy-concentration. CONCLUSION Amlodipine can depress the SBP and DBP with efficacy hysteresis.The most efficacy Emax(SBP:6.3±3.2 mmHg,DBP:10.1±2.9 mmHg) was appeared after administration 6-10 h.The efficacy hysteresis was better form on the antihypertensive effect in clinical therapy.
出处 《中国医院药学杂志》 CAS CSCD 北大核心 2011年第18期1511-1514,共4页 Chinese Journal of Hospital Pharmacy
关键词 氨氯地平 药动学 药效学 动脉收缩压 舒张压 amlodipinel pharmacokinetics pharmacodynamics SBP DBP
  • 相关文献

参考文献5

二级参考文献14

  • 1张琰,杨蕾,刘梅,覃华,陈笑艳,张逸凡,钟大放.苯磺酸氨氯地平片在健康人体的药动学及生物等效性评价[J].第四军医大学学报,2006,27(2):172-175. 被引量:33
  • 2杜光,刘东,刘宇,张冬林,刘喆隆,刘异,李飞娥.国产苯磺酸氨氯地平片的生物等效性[J].中国医院药学杂志,2007,27(2):185-187. 被引量:10
  • 3梁超,程晓华,张红,徐文炜,胡晓.LC-MS法评价两种苯磺酸氨氯地平片的人体生物等效性[J].第二军医大学学报,2007,28(3):299-301. 被引量:8
  • 4[3]Rojanasthien N,Teekachunhatean S,Jakob K,et al.Bioequivalence study of generic amlodipine in healthy Thai male volunteers[J].Int J Clin Pharmacol Ther,2004,42(6):330-335.
  • 5[5]Bhatt J,Singh S,Subbaiah G,et al.A rapid and sensitive liquid chromatography-tandem mass spectrometry(LC-MS-MS)method for the estimation of amlodipine in human plasma[J].Biomed Chromatogr,2007,21(2):169-175.
  • 6[7]Nirogi RV,Kandikere VN,Mudigonda K,et al.Sensitive and rapid liquid chromatography/tandem mass spectrometry assay for the quantification of amlodipine in human plasma[J].Biomed Chromatogr,2006,20(9):833-842.
  • 7[8]Massaroti P,Moraes LAB,Marchioretto MAM,et al.Development and validation of a selective and robust LC-MS-MS method for quantifying amlodipine in human plasma[J].Anal Bioanal Chem,2005,382(4):1049-1054.
  • 8Minushkina LO, Sidorenko BA. Metoprolol in the treatment of essential hypertension. Kardiologiia, 2003,43 ( 11 ) : 102-105.
  • 9Frishman Wh, Hainer JW, Sugg JM. FACT Study Group. A factorial study of combination hypertension treatment with metoprolol succinate extended release and felodipine extended release results of the Metoprolol Succinate - Felodipine Antihypertension Combination Trial (M - FACT). Am J Hypertens,2006,19 (4) :388-395.
  • 10Sheiner LB. Simultaneous modeling of pharmacokinetics and pharmacodynamics: application to d - tubocurarine. Clin Pharmacol Ther, 1979,25:358.

共引文献46

同被引文献54

  • 1方福生,李春霖.二甲双胍的临床应用及研究进展[J].中国药物应用与监测,2007,4(1):7-10. 被引量:8
  • 2李健华,顾学兰,邹建军,樊宏伟,肖大伟.HPLC-MS法测定血浆中氨氯地平的浓度及其药动学研究[J].药学与临床研究,2007,15(2):118-121. 被引量:8
  • 3叶平,孙晓楠.高血压与血脂异常[J].中国实用内科杂志,2007,27(12):914-916. 被引量:17
  • 4陈卿,吴健,伍建红,罗晓波,李正初.高血压患者长期服用氨氯地平对动脉弹性和左心室肥大的影响[J].中国动脉硬化杂志,2007,15(7):503-505. 被引量:10
  • 5孙尚文,路方红,孙颖,等.氨氯地平联合复方阿米洛利或替米沙坦对高血座患者颈动脉粥样硬化的对比研究.中华髙血压杂志,2011,19(8):763-767.
  • 6刘振东,范存芳,路方红,等.原发性髙血压左心室肥厚患者左心室应变率与心率震荡的关系.中华髙血压杂志,2011,19(5):469-473.
  • 7Esnault VL,Brown EA,Apetrei E,et al.The effects of am-lodipine and enalapril on renal function in adults with hyper-tension and nondiabetic nephropathies:a 3-year,randomized,multicenter,double-blind,placebo-controlled study.Clin T-her,2008,30(3):482.
  • 8关理.替米沙坦与苯磺酸氨氣地平片联合治疗对肾性髙血压和肾功能的影响.南京大学学报:医学版,2009,37(6):711-713.
  • 9吴学坤,蒋立新.肥胖型高血压的研究进展[J].中国循环杂志,2014,11(21):141-141.
  • 10GRIFFIN B R,SCHINSTOCK C A.Thinking Beyond New Clinical Guidelines:Update in Hypertension[J].Mayo Clin Proc,2015,90:273-279.

引证文献4

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部